Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dendritic Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01521143
What this trial is testing

Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment

Who this might be right for
Epithelial Ovarian Cancer
Prima BioMed Ltd 91
Testing effectiveness (Phase 2)WithdrawnNCT03014804
What this trial is testing

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Giant Cell GlioblastomaGliosarcomaOligodendroglioma+2 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01347034
What this trial is testing

Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)

Who this might be right for
Soft Tissue Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT02709993
What this trial is testing

Consolidation Therapy in Patients With Hematologic Malignancies

Who this might be right for
CancerHematologic Malignancies
Kiromic BioPharma Inc.
Early research (Phase 1)Active Not RecruitingNCT06325748
What this trial is testing

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

Who this might be right for
AML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies
Senti Biosciences 21
Testing effectiveness (Phase 2)Study completedNCT00940004
What this trial is testing

Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06846463
What this trial is testing

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

Who this might be right for
Diffuse Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
Virginia Commonwealth University 21
Early research (Phase 1)Study completedNCT00612001
What this trial is testing

Vaccine Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 8
Not applicableEnded earlyNCT00290628
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDiamond-blackfan AnemiaFanconi Anemia+6 more
Masonic Cancer Center, University of Minnesota 43
Large-scale testing (Phase 3)Study completedNCT01305200
What this trial is testing

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+24 more
Children's Oncology Group 226
Testing effectiveness (Phase 2)Study completedNCT02301611
What this trial is testing

Phase IIB TL + YCWP + DC in Melanoma

Who this might be right for
Melanoma
Elios Therapeutics, LLC 187
Testing effectiveness (Phase 2)Study completedNCT01068509
What this trial is testing

Ovarian Cancer Vaccine for Patients in Remission

Who this might be right for
Epithelial Ovarian Cancer
Prima BioMed Ltd 63
Not applicableStudy completedNCT00112593
What this trial is testing

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more
Fred Hutchinson Cancer Center 5
Early research (Phase 1)Study completedNCT00908362
What this trial is testing

Impact of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in Smokers

Who this might be right for
Smoke-related Lung DiseasesChronic Obstructive Pulmonary Disease
University of Rostock 45
Early research (Phase 1)WithdrawnNCT00944580
What this trial is testing

A Vaccine Study for High Risk Cancers

Who this might be right for
NeuroblastomaRhabdomyosarcomaOsteogenic Sarcoma
Penn State University
Testing effectiveness (Phase 2)Study completedNCT00027560
What this trial is testing

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Ended earlyNCT03063242
What this trial is testing

Sargramostim for Myeloid Dendritic Cell Deficiency

Who this might be right for
Kidney DiseasesKidney Transplant
University of Florida 4
Early research (Phase 1)Active Not RecruitingNCT03186118
What this trial is testing

Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia

Who this might be right for
CD 19+ Acute Leukemia
Seattle Children's Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT01697527
What this trial is testing

Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies

Who this might be right for
Malignant Neoplasm
Jonsson Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00059995
What this trial is testing

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Next Page